最終更新日：2025/11/30
Researchers reported that blisibimod reduced disease activity in patients with systemic lupus erythematosus during the clinical trial.
正解を見る
Researchers reported that blisibimod reduced disease activity in patients with systemic lupus erythematosus during the clinical trial.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
